Snehal khanna Blog

Patanjali has set a target of increasing the number to 25,000 in two years LATEST NEWS : A few years ago, Baba Ramdev’s Patanjali Ayurved had disrupted the market with its natural-herbal proposition, forcing major fast-moving consumer goods (FMCG) firms to follow the trend. After growing by leaps and bounds during the past five years, now it seems it is Patanjali’s turn to follow the conventional FMCG players to hold on to its success in the coming years. The firm, which so far has depended heavily on branded franchise outlets for growth, is now looking to aggressively expand its retail presence by taking the tried-and-tested channel distribution route that FMCG companies have been relying on for decades. While it currently has 5,000 distributors, Patanjali has set a target of increasing the number to 25,000 in the next two years. The move would be crucial to meet the ambitious target of annual sales of Rs 1,00,000 crore by 2020 set by its co-founder Baba Ramdev. “Whil...

Pharma stocks were the biggest losers with Nifty Pharma posting sixth consecutive session of loss Benchmark indices settled lower with Sensex shedding 200 points and Nifty ending below 9,400-level as investors booked profit in recent outperformers. The sentiment was also dragged by geopolitical tensions as Indian army strikes Pakistan military posts. The street also took cues from the global markets which were mostly trading lower post the explosion, at a concert by US singer Ariana Grande shook Manchester. The S&P BSE Sensex ended at 30,365, down 205 points, while the broader Nifty50 settled at 9,386, down 52 points. Read this: How taxmen nabbed black money hoarders who tried to beat the note ban The broader market underperformed the benchmark indices with S&P BSE Midcap and the S&P BSE Smallcap indices dipped over 1% each. "Investors became cautious after sudden hike in Indo-Pak tension. Additionally, higher than expected GST rate especiall...

Growing at its usual breakneck speed, Baba Ramdev’s  Patanjali  Group has clocked Rs 10,561 crore in sales during 2016-17. After increasing its revenue by a whopping 150 per cent the previous year, from Rs 2,006 crore in 2014-15 to Rs 5,000 crore in 2015-16, the Patanjali Group has managed to double its sales in the year ended March 31, 2017, cofounder Baba Ramdev announced on Thursday. As expected, the bulk of its revenue came from its fast moving consumer goods business, which is managed by Patanjali Ayurved Ltd (PAL). During the year, PAL’s sales stood at Rs 9,346 crore, followed by its ayurvedic and herbal medicines business, Divya Yog Pharmacy (Rs 870 crore). Patanjali Gramodyog Nyasm, a group trust that works in the animal husbandry sector and for the economic and social upliftment of villagers, generated Rs 345 crore. READ THIS: Patanjali and its grand plans: Ramdev expects Rs 20,000 cr revenue in FY18 In line with the market  trend, Patanjali cow ghee (...